Completed PHASE2 INTERVENTIONAL 2-arm
NCT07143097
Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer
Effect of Capecitabine as Maintenance Therapy Versus Observation on Patients With Early Stage Triple Negative Breast Cancer
Sponsor: Beni-Suef University
Conditions
Triple -Negative Breast Cancer
Interventions
capecitabine
Updated 1 time since 2025 Last updated: Aug 19, 2025 Started: Nov 1, 2021 Primary completion: Dec 30, 2024 Completion: May 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Triple -Negative Breast Cancer, this trial is completed. The trial is conducted by Beni-Suef University and has accumulated 1 data snapshot since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Completed — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Beni-Suef University
Data source: Beni-Suef University
For direct contact, visit the study record on ClinicalTrials.gov .